-
Study aim
-
the main objective of this study is evaluating the effect of duloxetine on post-operative pain in abdominal hysterectomy.
-
Design
-
This is a randomised double blind clinical trial (phase 2-3) with blinded postoperative care and outcome assessment. The number of subjects is 70. The subjects are divided in 2 groups randomly using table of random numbers.
-
Settings and conduct
-
This study is performed on patients with hysterectomy surgery in Afzalipoor Hospital of Kerman. The person who perform the intervention is a nurse out of this study which gives the patients drug or placebo, so anesthesiologist, the patient and data collector and analyzer are unaware of used drug.
-
Participants/Inclusion and exclusion criteria
-
This study is a clinical trial on patients who are admitted in Afzalipoor Hospital of Kerman for hysterectomy which are given consent to participation. Exclusion criteria are long term usage of opioids a analgesics, taking steroids, age less than 18 and higher than 85, pregnancy, history of heart, hepatic and renal failure, uncontrolled hypertension, endocrine disorders, BMI more than 40.
-
Intervention groups
-
Patients in case group receive oral duloxedine 60 mg, 2 hours prior to surgery and patients in control group receive placebo. Anesthesia technique and medication in both groups are identical.
-
Main outcome variables
-
In all cases, vital signs, complications of duloxetine and amount of analgesics given to patient are checked prior to anesthesia; just after commence of surgery; at the time of giving isoflurane; during surgery and after operation and recovery time, every 15 minutes. The intensity of pain after anesthesia until discharge from recovery is determined and recorded.
evaluation of pain in recovery is performed by means of Visual Analogue Scale (VAS). Patients discharged from recovery If they have scores of 9 or 10 according to aldrete scoring system. The amount of given analgesics in 24 hours is measured and overall patient satisfaction is assessed according to postoperative quality of recovery (QOR) score.